A pharmaceutical company that is specializing in development of generic version of anti-cancer drugs was in a path to enter multiple clinical trials with their generic version. For that they had the need to compare the drug side by side Vs the originators, but they found it challenging to source them.

Within 3 weeks Bio-Lead was already supplied the reference versions of Mabthera®, Opdivo® and Yervoy® through our strong network in Europe of drug wholesalers enabling parallel importation of originator drugs